LRRK2 and Parkinson disease: In addition to SNCA triplication, other PD-patient cells with mutations like LRRK2, PINK1, PARK2, and VPS35 were also successfully reprogrammed by the conventional OSKM/OSK factor and diverse differentiation methods117,123–128.